Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2012
Jun. 30, 2011
Cash flows from operating activities    
Net loss $ (18,854) $ (11,450)
Loss from discontinued operations, net of tax    1,353
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,782 1,818
Accretion of debt discount related to notes payable   2
Equity-based compensation - employees and non-employees 2,169 3,568
Loss from investments in investees 996 874
(Recovery of) provision for bad debt (91) 219
Provision for inventory reserves 754 316
Revenue from receipt of equity (102)  
Unrealized gain on investments, available for sale (1,140)  
Contingent consideration 2,109  
Changes in assets and liabilities of continuing operations, net of the effects of acquisitions:    
Accounts receivable (2,681) (1,936)
Inventory (3,321) 3,834
Prepaid expenses and other current assets (1,318) 19
Other assets 11 18
Accounts payable (796) (3,712)
Foreign currency measurement (109)  
Accrued expenses (87) (798)
Cash used in operating activities of continuing operations (17,678) (5,875)
Cash used in operating activities of discontinued operations (82) (2,691)
Net cash used in operating activities (17,760) (8,566)
Cash flows from investing activities    
Acquisition of businesses, net of cash (2,173) (10,538)
Purchase of marketable securities (17,117) (69,981)
Maturities of short-term marketable securities   14,982
Investments in investees (2,700)  
Capital expenditures (408) (542)
Net cash used in investing activities (22,398) (66,079)
Cash flows from financing activities:    
Issuance of common stock, including related parties, net   104,828
Purchase of common stock held in treasury   (7,832)
Redemption of Series A Preferred Stock   (1,792)
Borrowing under lines of credit 21,553 5,752
Repayments under lines of credit (16,288) (5,845)
Proceeds from the exercise of stock options and warrants 1,492 308
Net cash provided by financing activities 6,757 95,419
Effect of exchange rate changes on cash and cash equivalents 56 59
Net (decrease) increase in cash and cash equivalents (33,345) 20,833
Cash and cash equivalents at beginning of period 71,516 18,016
Cash and cash equivalents at end of period 38,171 38,849
SUPPLEMENTAL INFORMATION    
Interest paid 341 319
Income taxes refunded $ 197 $ 347